Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.020
0.00 (0.00%)
Feb 13, 2026, 9:48 AM EST - Market open

MRVI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
192.44259.19288.95883799.24284.1
Revenue Growth (YoY)
-30.47%-10.30%-67.28%10.48%181.32%98.48%
Cost of Revenue
151.9150.88148.74168.96140.5679.65
Gross Profit
40.54108.31140.2714.04658.68204.45
Selling, General & Admin
154.78161.77147.29125.76100.0694.25
Research & Development
18.1819.2217.2818.3715.226.42
Operating Expenses
172.95180.99164.57144.13115.28100.67
Operating Income
-132.42-72.68-24.37569.92543.4103.78
Interest Expense
-31.7-47.7-45.89-20.41-30.26-30.74
Interest & Investment Income
15.0927.427.732.34--
Other Non Operating Income (Expenses)
-4.07-2.38667.55-4.466.380.13
EBT Excluding Unusual Items
-153.09-95.36625.02547.38519.5273.17
Merger & Restructuring Charges
-7.391.21-10.57-3.5--
Impairment of Goodwill
-54.8-166.15----
Gain (Loss) on Sale of Assets
----11.2519
Other Unusual Items
-2.76-1.183.297.59--7.59
Pretax Income
-218.04-261.48617.74551.47530.7781.7
Income Tax Expense
-4.23-1.86756.1160.8161.522.88
Earnings From Continuing Operations
-213.81-259.62-138.38490.66469.2578.82
Minority Interest in Earnings
92.82114.7819.35-270.46-287.2110.16
Net Income
-121-144.85-119.03220.21182.0488.97
Preferred Dividends & Other Adjustments
-----12.08
Net Income to Common
-121-144.85-119.03220.21182.0476.89
Net Income Growth
---20.97%104.60%-
Shares Outstanding (Basic)
14413813213211510
Shares Outstanding (Diluted)
14413813225525829
Shares Change (YoY)
5.96%4.54%-48.33%-0.96%791.80%-88.61%
EPS (Basic)
-0.84-1.05-0.901.671.597.43
EPS (Diluted)
-0.84-1.05-0.901.671.562.36
EPS Growth
---6.97%-33.73%-
Free Cash Flow
-66.33-22.1960.67518.89353.72126.78
Free Cash Flow Per Share
-0.46-0.160.462.031.374.39
Gross Margin
21.07%41.79%48.52%80.87%82.41%71.96%
Operating Margin
-68.81%-28.04%-8.43%64.54%67.99%36.53%
Profit Margin
-62.88%-55.88%-41.19%24.94%22.78%27.06%
Free Cash Flow Margin
-34.47%-8.56%21.00%58.76%44.26%44.63%
EBITDA
-80.98-24.315.89601.75568.15129.62
EBITDA Margin
-42.08%-9.38%5.50%68.15%71.09%45.62%
D&A For EBITDA
51.4348.3840.2531.8424.7525.84
EBIT
-132.42-72.68-24.37569.92543.4103.78
EBIT Margin
-68.81%-28.04%-8.43%64.54%67.99%36.53%
Effective Tax Rate
--122.40%11.03%11.59%3.52%
Advertising Expenses
-3.52.92.51.31.2
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q